Novartis, a Switzerland-based pharmaceutical company, confirmed a report of two children dying from liver complications six weeks after taking its gene therapy drug, Zolgensma, Bloomberg reported Aug. 11.
Read the full post on Becker's Hospital Review - Healthcare News
